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Effects of central losartan on plasma renin and centrally mediated
natriuresis. Because intracerebroventricular (ICV) infusion of hypertonic
saline or angiotensin H (Ang II) both induce water drinking, vasopressin
secretion, natriuresis and increased arterial pressure, the possibility that
common neural pathways mediate responses to ICV Ang II and hyper-
tonic saline has been investigated. This was done by testing the effect of
ICV infusion of the Ang II antagonist losartan on the natriuretic and
pressor responses to ICV hypertonic NaCI in sheep. The effect of ICV
losartan on plasma renin concentration (PRC) was also investigated.
Infusion of losartan (1 mg/br) into a lateral ventricle prevented both
natriuretic and pressor responses to infusion of 0.6 mol/liter NaC1 into a
lateral ventricle at 1 mI/hr. In another experiment, ICY losartan at 1 mg/hr
caused a pronounced increase in the PRC of Na-depleted sheep, while
ICY Ang II at 3 1.tg/hr decreased PRC. The results suggest that: (i) a
central angiotensinergic pathway may mediate osmoregulatory responses
to centrally administered hypertonic saline, and (ii) a central angiotensin-
ergic pathway may have a tonic inhibitoiy influence on renin secretion in
Na-depleted animals.
Angiotensin II binding sites are found in several regions of the
central nervous system [1, 2]. Those located in sites lacking a
blood-brain barrier such as the subfornical organ, organum vas-
culosum of the lamina terminalis (OVLT) and area postrema are
probably receptors which respond to blood-borne Ang II, and
considerable evidence implicates these sites in water drinking,
vasopressin secretion and a centrally-mediated pressor response
stimulated by circulating Ang II [3—5]. Other central sites of Ang
11-binding (such as, paraventricular nucleus, median preoptic
nucleus and nucleus of the tractus solitarii) occur within the
blood-brain barrier and may represent Ang II receptors that are
activated by neurally released Ang II [5]. Some of these Ang II
receptors may also mediate the water drinking, natriuresis, in-
creased vasopressin secretion and pressor responses that have
been reported to be a consequence of intracerebroventricular
(ICV) infusion of Ang II [4, 6, 7]. Similar responses are caused by
ICV infusion of hypertonic saline [6, 8—12], raising the possibility
that an angiotensinergic pathway may be involved in responses to
ICV hypertonic saline.
This idea has been investigated in sheep by testing the effect of
central administration of the angiotensin II AT1 receptor antag-
onist losartan [13] on natriuretic and pressor responses to ICV
hypertonic saline. ICV infusion of Ang II also reduces plasma
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renin levels [14—16], suggesting that a central angiotensinergic
pathway may have an inhibitory influence on renin secretion. In
order to investigate this, the effect of ICV infusion of losartan on
plasma renin concentration of Na-depleted sheep was also tested.
Methods
A total of five merino-crossbreed ewes (2 to 3 years old) were
used. They were kept in individual metabolism cages, had access
to water except during experiments and were fed 0.8 kg of chaff
daily. Prior to experiments, the sheep underwent surgery which
involved oophorectomy, the enclosure of the carotid arteries in
bilateral skin ioops in the neck [17] and the implantation of guide
tubes over each lateral cerebral ventricle [18]. Sheep were anaes-
thetized for this surgery. Anaesthesia was induced with intrave-
ious sodium thiopentone (15 mg/kg) and maintained with
fluothane/oxygen inhalation. Several weeks elapsed following the
surgery before animals were used in experiments.
Experimental details
Effect of intracerebroventricular losartan on natriuretic and pres-
sor responses to intracerebroventricular infusion of hypertonic NaCl.
On the morning of the experiment, a catheter was inserted into
the bladder of the sheep and a heparinized cannula introduced
into the carotid artery. This cannula was attached to a pressure
transducer and the arterial pressure was registered on a Gould
2400 chart recorder throughout experiments. After one to two
hours, urine collections of 15 minutes duration were commenced.
At the same time, an infusion of either artificial cerebrospinal
fluid (CSF) or losartan (Dupont-Merck; 1 mg/mI in artificial CSF)
into the lateral ventricle at 1 ml/hr for three hours was com-
menced. The composition of artificial CSF has been described
previously [19]. One hour after the commencement of this ICV
infusion, 0.6 mol/liter NaC1 was included in the infusate for one
hour. Urine collections continued for a futher hour with the
continuation of the ICV infusion of artificial CSF or losartan.
Control experiments in which artificial CSF alone was infused into
the lateral ventricle for three hours were also completed. A blood
sample (10 ml) for measurement of plasma electrolyte concentra-
tions was obtained at one and two hours after the commencement
of the initial ICy infusion.
Effect of intracerebroventricular losartan on plasma renin concen-
tration of Na-depleted sheep. Sheep were depleted of Na by
introducing a polyethylene cannula into the parotid duct and
bringing it the exterior through the cheek, so that parotid saliva
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was drained from the animal for two days as described previously
[20]. Sheep were tranquilized with valium (0.25 mg/kg) and local
anaesthetic (lignocaine 20 mg/ml) was infiltrated around the
opening of the parotid duct for this procedure. Two days later, a
cannula was introduced into a carotid artery to allow the record-
ing of arterial pressure and the sampling of arterial blood for
estimation of plasma renin concentration (PRC), and plasma
electrolyte concentrations. Then an infusion of either artificial
CSF, losartan (Dupont-Merck; 1 mg/mI in artificial CSF), or Ang
II (Auspep, 3 xg/ml) in artificial CSF at 1 ml/hr into a lateral
ventricle for one hour was commenced. Blood samples (10 ml)
were obtained five minutes before and 30 and 60 minutes after the
commencement of the infusions. Further blood samples were
obtained at 30 minutes and 90 minutes after the cessation of the
ICV infusion of losartan. Losartan was also infused into the
jugular vein at 1 mg/hr for one hour in three sheep.
Analysis of plasma and urine samples
Blood samples for the measurement of PRC were collected into
tubes containing EDTA, cooled, then centrifuged and the plasma
obtained stored at —20°C. PRC was measured by radioimmuno-
assay of angiotensin I generated from the incubation of the
plasma sample with renin substrate using an antibody capture
technique [21]. Blood samples for measurement of plasma Na and
K concentration were centrifuged and the plasma obtained was
stored at 4°C. The Na and K concentration of plasma was
measured by ion selective electrode (Beckmann), and of urine by
flame photometry (Flame 4 autoanalyzer, Technicon).
Statistical methods
Results are expressed as mean and standard error of the mean.
Values of the renal Na excretion rate or PRC for each period of
time after the commencement of either hypertonic NaC1 or
losartan infusion have been compared with the pre-infusion value
using Dunnett's test after an analysis of variance. A paired t-test
was used to compare mean arterial pressure at the end of the ICY
infusions of hypertonic NaC1 or artificial CSF with the pre-
infusion values.
Results
Effect of JCV infusion of losartan on natriuretic and pressor
responses to ICV hypertonic NaCI
Infusion 0.6 mol/liter NaCI into a lateral ventricle for one hour
caused a gradual increase in the renal excretion of Na which
became significant on ending the infusion (Fig. 1). Arterial
pressure began to increase gradually approximately 30 minutes
after the commencement of the ICY infusion and had increased
by 8.3 1.3 mm Hg at the end of the hour long infusion of
hypertonic NaC1. Infusion of artificial CSF into the lateral ventri-
cle did not change renal Na excretion (renal Na excretion was 54
23 gmol/min for the first collection, and 53 23 tmol/min for
the final urine collection) or arterial pressure significantly (change
+1.0 0.7 mm Hg).
When an ICY infusion of losartan at 1 mg/hr preceded and
continued during the ICY infusion of 0.6 mol/liter NaCl, no
significant increase in renal Na excretion (Fig. 1) occurred. Mean
arterial pressure did not change (+0.8 0.5 mm Hg) significantly
from the pre-infusion level. Intravenous of infusion of losartan at
1 mg/hr did not block natriuretic (renal Na excretion increased
from 30 11 to 124 30 ixmol/min, or pressor responses to ICY
infusion of 0.6 mol/liter NaCl (mean arterial pressure change was
+9.3 3.3 mm Hg).
Effect of ICV infusion of angiotensin II or losartan on plasma
renin concentration of sodium depleted sheep
Removal of saliva from the parotid duct for two days resulted in
the PRC increasing to approximately 4 to 6 pmol angiotensin
I/mI/hr from the normal level of 0.1 to 1.2 pmol angiotensin
I/mI/hr when these sheep were Na-replete. Infusion of Ang II at 3
gg/hr into the lateral ventricle caused a pronounced reduction of
PRC within 30 minutes. PRC remained depressed at less than half
the pre-infusion value for the remainder of the ICY infusion and
for a further 30 minutes (Fig. 2). By contrast, ICY infusion of
losartan caused a pronounced increase in PRC within 30 minutes
of the commencement of the infusion in all four sheep tested (Fig.
2). This increase reached statistical significance 30 minutes after
the termination of the losartan infusion. ICY infusion of artificial
CSF (Fig. 2) or intravenous losartan (not shown) did not cause
any consistent changes in PRC. None of the above ICY infusions
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Fig. 1. Renal Na excretion in response to infusion of 0.6 mol/liter NaCI into
a lateral cerebral ventricle for one hour together with an intraventricular
infusion of either artificial CSF at 1 mi/hr (S 5, N = 4) or losartan at
1 mg/hr (O----Q N = 4) throughout the experiment A significant differ-
ence from the pre-infusion value is indicated by tP C 0.05, P C 0.01.
0
E0.
0
C
a)0C0
C.)
C
C
a)
E
(1)
a-
altered arterial pressure or had any consistent effect on plasma
[Na] or [K].
Discussion
The natriuretic and pressor responses that result from ICV
infusion of hypertonic NaCI in sheep are similar to those reported
for several other species [6, 8, 9]. These responses are also similar
to those induced by ICV infusion of Ang II [4, 6, 7], and are
prevented by centrally (but not peripherally) administered losar-
tan; which is a specific Ang II (AT1) antagonist [13]. Such results
suggest that a central angiotensinergic pathway may have been
activated by ICV hypertonic NaCI, and that responses to ICV
hypertonic NaCl and Ang II may at least in part, utilize common
neural circuitiy. Recently it has been shown that ICV losartan also
blocks water drinking in response to ICV infusion of hypertonic
saline [22]. Thus, it is likely that all osmoregulatory responses to
ICV hypertonic saline utilize Ang II in the central nervous system
for the production of these responses. The efferent pathway from
brain to kidney mediating this centrally induced natriuresis has
not been resolved fully, however, a factor(s) other than increased
arterial pressure, renal nerve activity and vasopressin secretion
appears to be involved [8, 10, 12].
ICV but not IV infusion of losartan also causes a pronounced
increase in PRC in Na-deplete sheep, whereas ICy Ang II
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Fig. 2. Plasma renin concentration in Na-depleted sheep in response to the natriuretic response to ICV hypertonic saline [27].
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